Acute actions of 3α-hydroxy-tibolone on factors influencing contraction in guinea-pig ventricular myocytes

European Journal of Pharmacology

Volumn 484, Issue 2-3, 2004, Pages 141-145

  Liew, Reginald ^a   Stagg, Mark A ^a   MacLeod, Kenneth T ^a   Collins, Peter ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Action potential; Ca2+ current, L type; Cell shortening; Estrogen receptor; Myocyte

Indexed keywords

3ALPHA HYDROXYTIBOLONE; ANTIESTROGEN; CALCIUM; CALCIUM CHANNEL L TYPE; ESTROGEN RECEPTOR; FULVESTRANT; ORG 4094; STEROID; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROPHYSIOLOGY; GUINEA PIG; HEART VENTRICLE CONTRACTION; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 1642464896     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.020     Document Type: Article

References (16)

1. Bjarnason N.H., Bjarnason K., Haarbo J., Rosenquist C., Christiansen C. Tibolone: prevention of bone loss in late postmenopausal women. J. Clin. Endocrinol. Metab. 81:1996;2419-2422.
2. Figtree G.A., Lu Y., Webb C.M., Collins P. Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation. 100:1999;1095-1101.
3. 2+ in guinea-pig isolated cardiac myocytes. Br. J. Pharmacol. 106:1992;739-745.
4. Kicovic P.M., Cortes-Prieto J., Luisi M., Milojevic S., Franchi F. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women. Reproduccion. 6:1982;81-91.
5. Kloosterboer H.J. Tibolone: a steroid with a tissue-specific mode of action. J. Steroid Biochem. Mol. Biol. 76:2001;231-238.
6. Lien E.A., Solheim E., Ueland P.M. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 51:1991;4837-4844.
7. Liew R., Stagg M.A., MacLeod K.T., Collins P. Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the L-type calcium current. J. Am. Coll. Cardiol. 41(6 (suppl. A)):2003;254A. (Abstract).
8. 2+ in isolated mammalian ventricular myocytes. J. Physiol. 444:1991;481-498.
9. Meyer R., Linz K.W., Surges R., Meinardus S., Vees J., Hoffmann A., Windholz O., Grohe C. Rapid modulation of L-type calcium current by acutely applied oestrogens in isolated cardiac myocytes from human, guinea-pig and rat. Exp. Physiol. 83:1998;305-321.
10. Nakajima T., Iwasawa K., Oonuma H., Morita T., Goto A., Wang Y., Hazama H. Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br. J. Pharmacol. 127:1999;429-440.
11. Sanjuan A., Castelo-Branco C., Colodron M., Ascaso C., Vicente J.J., Ordi J., Casals E., Mercade I., Escaramis G., Vanrell J.A. Effects of estradiol, cyproterone acetate, tibolone and raloxifene on uterus and aorta atherosclerosis in oophorectomized cholesterol-fed rabbits. Maturitas. 45:2003;59-66.
12. Simoncini T., Genazzani A.R. Tibolone inhibits leukocyte adhesion molecule expression in human endothelial cells. Mol. Cell. Endocrinol. 162:2000;87-94.
13. 2+, contraction, and potential in cardiac myocytes. Am. J. Physiol. 258:1990;H574-H586.
14. Williams J.K., Hall J., Anthony M.S., Register T.C., Reis S.E., Clarkson T.B. A comparison of tibolone and hormone replacement therapy on coronary artery and myocardial function in ovariectomized atherosclerotic monkeys. Menopause. 9:2002;41-51.
15. Zandberg P., Peters J.L.M., Demacker P.N.M., Smit M.J., de Reeder E.G., Meuleman D.G. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits. Arterioscler. Thromb. Vasc. Biol. 18:1998;1844.
16. Zoma W., Baker R.S., Lang U., Clark K.E. Hemodynamic response to tibolone in reproductive and nonreproductive tissues in the sheep. Am. J. Obstet. Gynecol. 184:2001;544-551.